Common variation in fatty acid metabolic genes and risk of incident sudden cardiac arrest.
暂无分享,去创建一个
D. Mozaffarian | T. Lehtimäki | T. Rea | P. Kwok | C. Albert | A. Chakravarti | K. Reinier | X. Jouven | S. Chugh | B. Psaty | D. Siscovick | H. Huikuri | D. Arking | B. Stricker | C. Newton-Cheh | J. Rotter | C. Johnson | C. Sitlani | R. Brugada | J. Brody | N. Sotoodehnia | S. Pulit | M. Müller-Nurasyid | J. Tardif | E. Larson | L. Lyytikäinen | Guo Li | P. Goyette | B. McKnight | S. Kääb | A. Mak | S. Hesselson | A. Huertas-Vazquez | M. Eijgelsheim | B. Krijthe | R. Lemaitre | P. Karhunen | I. King | Jennifer A. Brody | Colleen M. Sitlani | Ying A Wang | B. Psaty | C. Newton‐Cheh
[1] M. Peters,et al. Systematic identification of trans eQTLs as putative drivers of known disease associations , 2013, Nature Genetics.
[2] D. Arking,et al. The genetics of sudden cardiac death. , 2012, Annual review of genomics and human genetics.
[3] T. Rea,et al. Common Variation in Fatty Acid Genes and Resuscitation From Sudden Cardiac Arrest , 2012, Circulation. Cardiovascular genetics.
[4] F. Kuypers,et al. Phosphatidylcholine formation by LPCAT1 is regulated by Ca2+ and the redox status of the cell , 2012, BMC Biochemistry.
[5] K. Otsu,et al. Perilipin 5, a Lipid Droplet-binding Protein, Protects Heart from Oxidative Burden by Sequestering Fatty Acid from Excessive Oxidation*♦ , 2012, The Journal of Biological Chemistry.
[6] A. Shevchenko,et al. Human Lysophosphatidylcholine Acyltransferases 1 and 2 Are Located in Lipid Droplets Where They Catalyze the Formation of Phosphatidylcholine* , 2011, The Journal of Biological Chemistry.
[7] D. Allison,et al. Comparing self-reported ethnicity to genetic background measures in the context of the Multi-Ethnic Study of Atherosclerosis (MESA) , 2011, BMC Genetics.
[8] D. Mozaffarian,et al. Endogenous red blood cell membrane fatty acids and sudden cardiac arrest. , 2010, Metabolism: clinical and experimental.
[9] K. Lunetta,et al. Methods in Genetics and Clinical Interpretation Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium Design of Prospective Meta-Analyses of Genome-Wide Association Studies From 5 Cohorts , 2010 .
[10] A. Yamashita,et al. Involvement of ACSL in local synthesis of neutral lipids in cytoplasmic lipid droplets in human hepatocyte HuH7 Published, JLR Papers in Press, March 22, 2007. , 2007, Journal of Lipid Research.
[11] Takao Shimizu,et al. Cloning and Characterization of Mouse Lung-type Acyl-CoA:Lysophosphatidylcholine Acyltransferase 1 (LPCAT1) , 2006, Journal of Biological Chemistry.
[12] T. Osumi,et al. MLDP, a Novel PAT Family Protein Localized to Lipid Droplets and Enriched in the Heart, Is Regulated by Peroxisome Proliferator-activated Receptor α* , 2006, Journal of Biological Chemistry.
[13] S. Gabriel,et al. Efficiency and power in genetic association studies , 2005, Nature Genetics.
[14] J. Falck,et al. Enhancement of Cardiac L-Type Ca2+ Currents in Transgenic Mice with Cardiac-Specific Overexpression of CYP2J2 , 2004, Molecular Pharmacology.
[15] A. Lusis,et al. Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. , 2004, The New England journal of medicine.
[16] R. Natarajan,et al. 12/15-Lipoxygenase Activity Mediates Inflammatory Monocyte/Endothelial Interactions and Atherosclerosis in Vivo* , 2004, Journal of Biological Chemistry.
[17] M. Ziolo,et al. Effects of arrhythmogenic lipid metabolites on the L-type calcium current of diabetic vs. non-diabetic rat hearts , 2001, Molecular and Cellular Biochemistry.
[18] C. Carlson,et al. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. , 2004, American journal of human genetics.
[19] Thomas Lumley,et al. Diuretic therapy, the alpha-adducin gene variant, and the risk of myocardial infarction or stroke in persons with treated hypertension. , 2002, JAMA.
[20] T. Raghunathan,et al. Sudden death and myocardial infarction in first degree relatives as predictors of primary cardiac arrest. , 2002, Atherosclerosis.
[21] J. Manson,et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. , 2002, The New England journal of medicine.
[22] Alex P. Reiner,et al. Diuretic Therapy, the α-Adducin Gene Variant, and the Risk of Myocardial Infarction or Stroke in Persons With Treated Hypertension , 2002 .
[23] T. Lu,et al. Activation of ATP‐sensitive K+ channels by epoxyeicosatrienoic acids in rat cardiac ventricular myocytes , 2001, The Journal of physiology.
[24] George A. Mensah,et al. Sudden Cardiac Death in the United States, 1989 to 1998 , 2001, Circulation.
[25] D. Siscovick,et al. Reducing mortality from sudden cardiac death in the community: lessons from epidemiology and clinical applications research. , 2001, Cardiovascular research.
[26] R. Virmani,et al. Sudden cardiac death. , 1987, Human pathology.
[27] G. J. van der Vusse,et al. Cardiac fatty acid uptake and transport in health and disease. , 2000, Cardiovascular research.
[28] P Ducimetière,et al. Predicting sudden death in the population: the Paris Prospective Study I. , 1999, Circulation.
[29] A. Leaf,et al. Differential effects of various eicosanoids on the production or prevention of arrhythmias in cultured neonatal rat cardiac myocytes. , 1997, Prostaglandins.
[30] T. Raghunathan,et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. , 1995, JAMA.
[31] P. Corr,et al. Selected metabolic alterations in the ischemic heart and their contributions to arrhythmogenesis. , 1995, Herz.
[32] G. Lopaschuk,et al. Triacylglycerol turnover in isolated working hearts of acutely diabetic rats. , 1994, Canadian journal of physiology and pharmacology.
[33] G. Lopaschuk,et al. Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts. , 1994, The American journal of physiology.
[34] J. Booth,et al. Resampling-Based Multiple Testing. , 1994 .
[35] J. Parratt,et al. Failure of cyclo-oxygenase inhibition to protect against arrhythmias induced by ischaemia and reperfusion: implications for the role of prostaglandins as endogenous myocardial protective substances. , 1991, Cardiovascular research.
[36] J. Parratt,et al. The Effects of L655,240, a Selective Thromboxane and Prostaglandin Endoperoxide Antagonist, on Ischemia‐ and Reperfusion‐Induced Cardiac Arrhythmias , 1988, Journal of cardiovascular pharmacology.
[37] J J Heger,et al. Sudden cardiac death. , 1998, Circulation.
[38] W. Lands. Metabolism of glycerolipides; a comparison of lecithin and triglyceride synthesis. , 1958, The Journal of biological chemistry.